MMP9 and breast cancer: The tissue levels of at least MMP-1, MMP-2, MMP-9, MMP-11, membrane type (MT) 1-MMP, tissue inhibitors of metalloproteinases (TIMP) 1 and TIMP-2 have been correlated with poor outcome of breast cancer patients [20,23,24].